Global Insights: Peptide Antibiotics Market Expected to Surpass $8.29 Billion by 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#What Is the Estimated Industry Valuation for the Peptide Antibiotics Sector?#_x000D_
The market size of peptide antibiotics has witnessed a robust growth in the past few years. It is projected to increase from $5.25 billion in 2024 to $5.77 billion in 2025, registering a compound annual growth rate (CAGR) of 9.8%. The substantial growth observed during the historical period is due to the emergence and advancement in peptide antibiotics, an increase in antibiotic resistance, an upsurge in infectious diseases, progress in peptide synthesis technologies, and expansion of the pharmaceutical industry._x000D_
_x000D_
The market size for peptide antibiotics is anticipated to experience robust growth in the coming years. It’s projected to reach $8.29 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 9.5%. The anticipated growth during the forecast period can be credited to the emphasis on developing new antibiotics, a rise in global antibiotic-resistant infections, an increase in research and development in antimicrobial peptides, and regulatory support for novel antibiotic approvals. Key trends expected during the forecast period include researching natural sources for antimicrobial peptides, using peptide antibiotics in animal healthcare, concentrating on peptide engineering for improved efficacy, creation of combination peptide antibiotics, and the inclusion of artificial intelligence and machine learning in the discovery of peptide antibiotics._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp_x000D_
_x000D_
#What Forces Are Driving The Growth Of The Peptide Antibiotics Market?#_x000D_
The escalation in the occurrence of various infectious diseases is set to boost the expansion of the peptide antibiotics market. Such diseases are triggered by harmful micro-organisms like bacteria, fungi, parasites, among others. The surge in infectious diseases can be attributed to swift urbanization, climate alteration, heightened risk of disease onset, and more, thereby augmenting the need for peptide antibiotics. Peptide antibiotics are known to disrupt the cell membranes physically and bolster antibacterial activity. For example, in May 2024, the World Health Organization, an intergovernmental organization based in Switzerland, reported that by April 2024, the number of dengue cases in the America region had exceeded seven million. This number is significantly larger than the 4.6 million cases reported in 2023. Consequently, the increase in infectious disease rates is propelling the growth of the peptide antibiotics market._x000D_
_x000D_
#How Is The Peptide Antibiotics Industry Segmented Across Key Parameters?#_x000D_
The peptide antibiotics market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics_x000D_
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs_x000D_
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases_x000D_
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels_x000D_
_x000D_
Subsegments:_x000D_
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides _x000D_
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides_x000D_
_x000D_
#What Notable Trends Are Shaping The Direction Of The Peptide Antibiotics Market?#_x000D_
The development of strategic alliances is an emerging trend in the peptide antibiotics sector. Prominent firms in the peptide antibiotics marketplace are forming alliances to broaden their markets and exploit mutual resources. For instance, in January 2022, Berkeley Lights, an American digital cell biology corporation, collaborated with Aanika Biosciences. In the context of this alliance, Aanika will make use of the high-throughput, functional screening service of Berkeley Lights to rapidly identify and fine-tune functional antimicrobial peptides (AMPs) for the eradication of harmful bacteria, primarily those leading to outbreaks of foodborne illnesses. Moreover, the Beacon Optofluidic Platform will facilitate the recognition of bacteria-damaging peptides, for the invention of an unprecedented antibacterial tag. This tag will be implemented in their bacterial spore-based barcoding technology to safeguard the food supply chain. Aanika Biosciences is an American biotech firm._x000D_
_x000D_
#Which Companies Currently Dominate The Competitive Landscape In The Peptide Antibiotics Industry?#_x000D_
Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG _x000D_
_x000D_
#Get The Full Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report_x000D_
_x000D_
#Which Geographic Regions Are Driving Demand In The Peptide Antibiotics Market?#_x000D_
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
